Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Cdk1/Cyc B-IN-1 | 2459916-56-2 | 98.5% | 353.85 | 50 MG
SDP

Catalog No. 5000362219
Encompass_Preferred

CDK1/Cyc B-IN-1 (Compound 5) is a selective CDK1/Cyc B complex inhibitor with an IC50 of 97 nM. It triggers apoptosis and G2/M cell cycle arrest and demonstrates broad-spectrum cytotoxic action against cancer cell lines. In vitro, it is soluble in DMSO at 100 mg/mL.

  • Induces apoptosis and G2/M cell cycle arrest
  • Exhibits cytotoxic activity against HCT-116 cells (IC50 of 5.33 ± 0.69 μM)
  • Exhibits cytotoxic activity against WI-38 cells (IC50 of 21.69 ± 1.04 μM)
  • Shows antiproliferative activity against various human cancer cell lines

Catalog No. 50-003-62219 Supplier Medchemexpress LLC Supplier No. HY14764650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

CDK1/Cyc B-IN-1 (Compound 5) is a selective CDK1/Cyc B complex inhibitor with an IC50 of 97 nM. It triggers apoptosis and G2/M cell cycle arrest and demonstrates broad-spectrum cytotoxic action against cancer cell lines. In vitro, it is soluble in DMSO at 100 mg/mL.

  • Induces apoptosis and G2/M cell cycle arrest
  • Exhibits cytotoxic activity against HCT-116 cells (IC50 of 5.33 ± 0.69 μM)
  • Exhibits cytotoxic activity against WI-38 cells (IC50 of 21.69 ± 1.04 μM)
  • Shows antiproliferative activity against various human cancer cell lines

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.